Rabies Post-Exposure Prophylaxis for a 20.8 kg Child
For a 20.8 kg child requiring rabies post-exposure prophylaxis when non-human monoclonal antibody is not preferred, administer human rabies immune globulin (HRIG) at 416 IU (20 IU/kg × 20.8 kg) infiltrated into and around the wound on day 0, combined with a 4-dose rabies vaccine series (1.0 mL intramuscularly on days 0,3,7, and 14) injected in the deltoid or anterolateral thigh. 1, 2, 3
Immediate Wound Management
- Thoroughly wash all wounds with soap and water for 15 minutes immediately—this is the single most effective measure for preventing rabies infection. 2, 3
- Follow with irrigation using a virucidal agent such as povidone-iodine solution if available. 1, 2
Human Rabies Immune Globulin (HRIG) Administration
- Calculate the exact dose: 20 IU/kg × 20.8 kg = 416 IU total. 1, 2, 4
- Administer on day 0, ideally simultaneously with the first vaccine dose. 1, 2, 3
- Infiltrate as much of the calculated 416 IU as anatomically feasible directly into and around the wound site. 1, 2, 5
- Inject any remaining volume intramuscularly at a site distant from vaccine administration (never in the same anatomical location as the vaccine). 1, 2, 3
- Do not exceed 20 IU/kg—higher doses suppress active antibody production from the vaccine. 2, 3, 6
- If HRIG was not given on day 0, it can still be administered up to and including day 7 after the first vaccine dose, but not beyond day 7. 3, 5
Rabies Vaccine Administration
- Administer human diploid cell vaccine (HDCV) or purified chick embryo cell vaccine (PCECV), 1.0 mL per dose intramuscularly. 1, 2, 6
- Vaccine schedule: days 0,3,7, and 14 (day 0 is the day the first dose is administered). 1
- For this child, inject in the deltoid muscle if the child is older, or in the anterolateral thigh if the child is young. 1, 2, 6
- Never use the gluteal area—this produces inadequate antibody response and is associated with vaccine failure. 1, 2, 6
- Children receive the same vaccine dose volume (1.0 mL) as adults. 2, 3, 6
Critical Timing Considerations
- Initiate post-exposure prophylaxis as soon as possible after exposure, ideally within 24 hours. 2, 3
- However, treatment should be administered regardless of time elapsed since exposure, as rabies incubation periods can exceed one year and the disease is uniformly fatal once symptoms appear. 3, 6
- Delays of a few days for individual vaccine doses are acceptable and do not compromise protection. 3
Special Populations Requiring Modified Regimens
- If the child is immunocompromised (corticosteroid use, HIV, other immunosuppressive conditions), upgrade to a 5-dose vaccine regimen on days 0,3,7,14, and 28, plus HRIG at 20 IU/kg on day 0. 1, 2, 3
- Immunocompromised patients require mandatory serologic testing 1-2 weeks after the final vaccine dose to confirm adequate antibody response. 3, 6
- If the child was previously vaccinated (completed pre-exposure or prior post-exposure prophylaxis with cell culture vaccine), administer only 2 vaccine doses on days 0 and 3, and do NOT give HRIG. 1, 2, 3
Common Pitfalls to Avoid
- Never administer HRIG and vaccine in the same syringe or at the same anatomical site—this interferes with vaccine efficacy. 1, 2, 3
- Never use the gluteal area for vaccine administration—multiple vaccine failures have been documented with this route. 1, 2, 6
- Never give HRIG to previously vaccinated persons—it will suppress the anamnestic antibody response. 2, 3, 6
- Never exceed 20 IU/kg of HRIG—higher doses partially suppress active antibody production. 2, 3, 6
- Do not withhold treatment while waiting for animal observation results if the exposure occurred in a rabies-endemic area. 3
Rationale for HRIG Over Non-Human Monoclonal Antibodies
The question specifically states that non-human monoclonal antibody is not preferred. HRIG remains the standard of care recommended by the CDC and ACIP for passive immunization in rabies post-exposure prophylaxis. 1, 2, 5 The combination of HRIG and vaccine is nearly 100% effective when administered promptly and appropriately. 2, 3, 7
Human rabies is nearly 100% fatal once clinical symptoms develop, making proper post-exposure prophylaxis absolutely critical. 7, 8, 9 No case of human rabies in the United States has ever been attributed to receiving proper post-exposure prophylaxis according to current ACIP recommendations. 3